Fibrosis: Clinical Trials

19 trials for Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 terminated. 19 Phase 1, 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 119Terminated 19
Phase 29Terminated 9

Follow Fibrosis: new trials by email Literature Review of Fibrosis trials Research Report on Fibrosis

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH.
AZD7503 - Steatohepatitis
Phase 1TerminatedAstraZeneca402023-03-312025-07-20
Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects
ID119031166M, Placebo - Healthy Participants
Phase 1TerminatedIlDong Pharmaceutical Co Ltd672022-10-102024-07-11
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease
BMS-963272, Placebo matching BMS-963272 - Nonalcoholic Fatty Liver Disease
Phase 1TerminatedBristol-Myers Squibb92021-02-242022-06-09
Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis
Align Probiotic Supplement Capsule, Placebos - Fatty Liver Disease, Fibrosis, Liver
Phase 1 / Phase 2TerminatedCorewell Health East142021-01-122022-09-27
TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis
TD-1058, Placebo - Idiopathic Pulmonary Fibrosis (IPF)
Phase 1TerminatedTheravance Biopharma722020-10-152022-02-23
Losartan to Improve Hip Microfracture
Losartan, Placebo - Hip Osteoarthritis, Hip Impingement Syndrome
Phase 1 / Phase 2TerminatedSteadman Philippon Research Institute12020-08-072023-10-30
Safety, Tolerability and Pharmacodynamics of SYNB1020
SYNB1020, Placebo - Cirrhosis
Phase 1 / Phase 2TerminatedSynlogic232018-03-192021-05-13
Hypertrophic Scar Prevention by Novel Topical Gel Application
Pentamidine Isethionate, Placebo - Hypertrophic Scar
Phase 1 / Phase 2TerminatedMayo Clinic62018-03-052023-11-22
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
Laboratory Biomarker Analysis, Magnetic Resonance Imaging, Radiation Therapy - Cholangiocarcinoma, Cirrhosis
Phase 1TerminatedM.D. Anderson Cancer Center362016-02-152026-06-17
A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis
IV bolus injection of Sildenafil - Cirrhosis
Phase 1TerminatedUniversity of Maryland, Baltimore22014-05-012022-11-15
Study to Evaluate Fractional Collagen Synthesis Within Keloid Scars and Identify Biomarkers of Keloid Scars
Triamcinolone acetonide, Placebo - Fibrosis
Phase 1TerminatedGlaxoSmithKline92014-04-152017-05-15
Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER)
Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs), matched placebo - Idiopathic Pulmonary Fibrosis (IPF)
Phase 1TerminatedJoshua M Hare92013-11-132021-03-09
A Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures
ICX-RHY-013 - Restrictive Scar Contracture, Restrictive Hypertrophic Scar
Phase 1 / Phase 2TerminatedUniversity of Pittsburgh152011-01-012017-07-11
ST266 Versus Standard Care In Treating Partial Thickness Burns
ST266 - Burns
Phase 1 / Phase 2TerminatedNoveome Biotherapeutics, formerly Stemnion162009-06-012019-05-15
Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells
adipose tissue derived stromal cells - Liver Cirrhosis
Phase 1TerminatedKanazawa University62009-02-012012-10-18
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Losartan, Zileuton, N-Acetylcysteine - Hermansky-Pudlak Syndrome (HPS), Pulmonary Fibrosis
Phase 1 / Phase 2TerminatedNational Human Genome Research Institute (NHGRI)32007-04-012013-08-02
Safety Study of Autologous Stem Cell in Liver Cirrhosis
Autologous bone marrow-derived mononuclear cells infusion - Liver Cirrhosis
Phase 1 / Phase 2TerminatedUniversidade Federal do Rio de Janeiro152005-11-012008-04-03
Treatment of Early Systemic Sclerosis by Bosentan
bosentan - Systemic Sclerosis (Scleroderma)
Phase 1 / Phase 2TerminatedRikshospitalet University Hospital302005-01-012009-06-12
Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome
pentoxifylline - Hepatopulmonary Syndrome
Phase 1TerminatedUniversity of Alabama at Birmingham92004-06-012015-03-09

Narrower conditions

Liver Cirrhosis (5)  ·  Pulmonary Fibrosis (3)  ·  Cicatrix (2)  ·  Fatty Liver (2)  ·  Idiopathic Pulmonary Fibrosis (2)  ·  Non-alcoholic Fatty Liver Disease (2)  ·  Albinism (1)  ·  Albinism, Oculocutaneous (1)  ·  Burns (1)  ·  Camurati-Engelmann Syndrome (1)  ·  Carcinoma, Hepatocellular (1)  ·  Cholangiocarcinoma (1)  ·  Cicatrix, Hypertrophic (1)  ·  Hepatopulmonary Syndrome (1)

Broader conditions

Pathologic Processes (19)  ·  Pathological Conditions, Signs and Symptoms (19)  ·  Digestive System Diseases (8)  ·  Liver Diseases (8)  ·  Respiratory Tract Diseases (4)  ·  Lung Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Cicatrix (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Connective Tissue Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Lung Diseases, Interstitial (2)  ·  Signs and Symptoms (2)  ·  Skin Diseases (2)

Interventions

Losartan (2)  ·  Acetylcysteine (1)  ·  Bosentan (1)  ·  Erythromycin (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Pentamidine (1)  ·  Pentoxifylline (1)  ·  Pravastatin (1)  ·  Probiotics (1)  ·  Radiation (1)  ·  Radiotherapy (1)  ·  Sildenafil Citrate (1)  ·  Triamcinolone Acetonide (1)  ·  zileuton (1)

Sponsors

AstraZeneca (1)  ·  Bristol-Myers Squibb (1)  ·  Corewell Health East (1)  ·  GlaxoSmithKline (1)  ·  IlDong Pharmaceutical Co Ltd (1)  ·  Joshua M Hare (1)  ·  Kanazawa University (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  National Human Genome Research Institute (NHGRI) (1)  ·  Noveome Biotherapeutics, formerly Stemnion (1)  ·  Rikshospitalet University Hospital (1)  ·  Steadman Philippon Research Institute (1)  ·  Synlogic (1)  ·  Theravance Biopharma (1)

Countries

United States (14)  ·  United Kingdom (2)  ·  Brazil (1)  ·  Japan (1)  ·  Norway (1)  ·  Puerto Rico (1)

Top investigators

Alexander Meves, MD (1)  ·  David L Steed, MD (1)  ·  Eugene J Koay (1)  ·  Guilherme FM Rezende, MD, PhD (1)  ·  J. Peter Rubin, MD (1)  ·  Jan T Gran, Professor (1)  ·  Marc J Philippon, MD (1)  ·  Marilyn K. Glassberg, MD (1)  ·  Mariquit Sendelbach, DO (1)  ·  Michael B Fallon, MD (1)  ·  Shuichi Kaneko, M.D. (1)  ·  Thomas Markello, M.D. (1)

Results publications

PMID 18668653, PMID 26143343, PMID 38730548, PMID 41825097

NIH funding

P30CA016672 (1), R03DK065958 (1)